News Sentiment

INGN sentiment intelligence

Inogen Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 60 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 6.54 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

77/100 classification confidence.

Company focus 49

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

-0.9% over one week, +2.2% over four weeks, trend active, and near fair-value range.

Latest direct headline Neutral

Inogen to report second quarter 2026 results on August 6

Market Reaction

Balanced read

51/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 77/100 classification
One-week reaction -0.9% Price digesting
Trend fit Trend active 2.2% over four weeks
Fair value -13.3% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 11
Neutral 47
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 49
Industry context 11
Sector context 0

Sources

Coverage mix

Publishers
Market source 14
Stock Titan 11
TradingView 6
TradingKey 5
StockStory 2
scanx.trade 1
Business Wire 1
Quartr 1

Event Lens

What the news is about

Classified themes
Market update 28
Earnings 27
Balance sheet 2
Macro sensitivity 1
Regulatory and legal 1
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 60
scanx.trade Direct company coverage

Inogen to report second quarter 2026 results on August 6

Inogen will release its second quarter 2026 financial results after market close on Thursday, August 6, 2026. The medical technology company will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss its performance. Investors can access the live webcast or a replay, w

Tone
Neutral 50/100
Event
Earnings
Published
16 Jul 2026 14:10
Source
scanx.trade
Quartr Direct company coverage

Inogen (INGN) Stifel 2024 Healthcare Conference Summary

Inogen (INGN) shared a summary of their Stifel 2024 Healthcare Conference, detailing efforts in leadership and culture transformation under new CEO and CFO focused on growth, profitability, and innovation. The company is rebaselining its DTC business for profitability, scrutinizi

Tone
Positive 65/100
Event
Market update
Published
11 Jul 2026 08:10
Source
Quartr
Investing.com Nigeria Direct company coverage

Form 4 Inogen Inc For: 9 July By Investing.com

This article reports on a Form 4 filing for Inogen Inc (IGN) relating to transactions on July 9, 2026. The brief piece indicates that Inogen Inc. has a stock symbol INGN and includes its current performance at the time of publication. The content primarily serves as a notificatio

Tone
Neutral 50/100
Event
Market update
Published
09 Jul 2026 14:10
Source
Investing.com Nigeria
Stock Titan Direct company coverage

Inogen (INGN) EVP, COO awarded 130,000 restricted stock units vesting from 2026

Inogen Inc.'s EVP and COO, Andrew P. Reding, has been granted 130,000 restricted stock units (RSUs). These RSUs will begin vesting on September 1, 2026, with one-third vesting after one year and the remaining units vesting in equal annual installments, contingent on his continued

Tone
Neutral 50/100
Event
Market update
Published
09 Jul 2026 13:11
Source
Stock Titan
Stock Titan Direct company coverage

Inogen (INGN) EVP, COO Andrew Reding files baseline Form 3 insider report

Inogen Inc.'s EVP and COO, Andrew P. Reding, has filed an initial Form 3 with the SEC, establishing his status as an insider with the company. This filing is a baseline report of beneficial ownership and does not indicate any purchases, sales, or other transactions of company sha

Tone
Neutral 50/100
Event
Market update
Published
09 Jul 2026 13:11
Source
Stock Titan
Stock Titan Direct company coverage

Inogen Inc (INGN) executive sells 10,938 shares in planned trade

Jennifer M. Yi Boyer, EVP Enterprise Enablement and Chief HR Officer at Inogen Inc (INGN), sold 10,938 shares of company common stock for $6.5959 per share on July 1, 2026. This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on February 27, 2026.

Tone
Negative 37/100
Event
Market update
Published
06 Jul 2026 20:10
Source
Stock Titan
Finviz Direct company coverage

INGN - Inogen Inc Volatility & Greeks

This article provides a detailed overview of Inogen Inc (INGN) financial data, including its stock performance, volatility metrics, and various financial ratios. It covers key figures such as market capitalization, sales, earnings per share, insider and institutional ownership, a

Tone
Neutral 50/100
Event
Earnings
Published
03 Jul 2026 17:09
Source
Finviz
The Globe and Mail Direct company coverage

Inogen Appoints New Chief Operating Officer for Growth

Inogen has appointed Andy Reding as its new Chief Operating Officer, a move aimed at strengthening its leadership and execution capabilities to support diversification, new product launches, and geographic expansion. Reding brings over 30 years of experience in medical technology

Tone
Neutral 50/100
Event
Market update
Published
03 Jul 2026 03:10
Source
The Globe and Mail
BioSpace Direct company coverage

Inogen Announces the Appointment of Andy Reding as Chief Operating Officer

Inogen, Inc. (Nasdaq: INGN) has appointed Andy Reding as its new Chief Operating Officer, a newly created role aimed at strengthening leadership and driving commercial and operational execution. Reding brings over 30 years of medical technology and commercial operations experienc

Tone
Positive 73/100
Event
Market update
Published
02 Jul 2026 04:10
Source
BioSpace
Moomoo Direct company coverage

Inogen Appoints Reding to New COO Role

Inogen has appointed Jason Reding as its new Chief Operating Officer, a newly created role within the company. Reding brings extensive experience in general management, operations, and supply chain across various industries, including medical devices. This strategic hire is expec

Tone
Positive 65/100
Event
Macro sensitivity
Published
02 Jul 2026 03:10
Source
Moomoo
Investing.com Direct company coverage

Inogen appoints Andy Reding as chief operating officer

Inogen Inc. has appointed Andy Reding as its new Chief Operating Officer, a newly created position aimed at strengthening its leadership structure. Reding brings over 30 years of experience in medical technology and will be responsible for revenue and operational performance, ali

Tone
Positive 64/100
Event
Earnings
Published
01 Jul 2026 21:09
Source
Investing.com
Stock Titan Direct company coverage

Inogen Inc SEC Filing

This SEC Form 144 filing indicates a proposed sale of 10,770 shares of Inogen Inc. (INGN) common stock by Jennifer Yi Boyer, dated May 29, 2026, under a 10b5-1 plan. The filing also notes 10,938 Restricted Stock Units acquired on March 1, 2025, with Morgan Stanley Smith Barney LL

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 21:09
Source
Stock Titan
Stock Titan Direct company coverage

Inogen (Nasdaq: INGN) adds COO Andy Reding with equity package

Inogen (Nasdaq: INGN) has appointed Andy Reding as its new Chief Operating Officer, effective July 6, 2026, a newly created role to drive revenue, operations, and cross-functional execution for new products and geographic expansion. Reding's compensation package includes a $500,0

Tone
Positive 63/100
Event
Earnings
Published
01 Jul 2026 20:09
Source
Stock Titan
Stock Titan Direct company coverage

[144] Inogen Inc SEC Filing

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 07:00
Source
Stock Titan
TradingView Direct company coverage

Inogen, Inc. Financial Disclosures & Filings

This page provides a comprehensive list of Inogen, Inc.'s financial disclosures and filings, including earnings reports, annual general meetings, corporate presentations, and investor conference transcripts from 2022 to 2026. These documents offer insights into the company's fina

Tone
Positive 67/100
Event
Earnings
Published
01 Jul 2026 03:40
Source
TradingView
TradingView Direct company coverage

Inogen, Inc. Actuals & Estimates (NASDAQ:INGN)

This article provides an overview of Inogen, Inc.'s (NASDAQ: INGN) financial actuals and estimates, including its current stock price, historical performance, analyst forecasts, and upcoming earnings report. It highlights the company's financial data, such as market capitalizatio

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 05:40
Source
TradingView
TradingView Direct company coverage

Inogen, Inc. Actuals & Estimates (SWB:6IO)

This article provides financial actuals and estimates for Inogen, Inc. (SWB:6IO), including income statement, balance sheet, and cash flow data, alongside analyst price targets. It details the company's past earnings and revenue, future earnings report dates, and key financial me

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 01:40
Source
TradingView
TradingView Direct company coverage

Price to sales forward of Inogen, Inc – NASDAQ:INGN

This article displays the "Price to sales forward" metric for Inogen, Inc (NASDAQ: INGN) on the TradingView platform. The content is primarily a representation of financial data for the company, showing a period, value, change, and percentage change without specific figures in th

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 18:40
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of Inogen, Inc – NASDAQ:INGN

This article provides financial information for Inogen, Inc (NASDAQ: INGN), specifically its enterprise value to revenue forward. It appears to be a stub or an incomplete data entry from a financial platform like TradingView, as it lacks detailed analytical content beyond the sta

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 18:39
Source
TradingView
Stock Traders Daily Direct company coverage

Precision Trading with Inogen Inc (INGN) Risk Zones

This article provides a precision trading analysis for Inogen Inc (INGN), detailing neutral readings in shorter horizons and suggesting an easing of a long-term weak bias. It highlights an exceptional 49.5:1 risk-reward setup targeting a 15.8% gain versus 0.3% risk, and outlines

Tone
Neutral 50/100
Event
Market update
Published
19 Jun 2026 12:32
Source
Stock Traders Daily
TradingKey Direct company coverage

Inogen Inc (INGN) Institutional Confidence

The article analyzes Inogen Inc's (INGN) institutional confidence score, which is currently 7.00, placing it 79th in its industry. Institutional shareholding rose by 4.39% quarter-over-quarter to 75.89%, with Steven Cohen being the largest shareholder despite a slight decrease in

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 08:14
Source
TradingKey
TradingKey Direct company coverage

Inogen Inc (INGN) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Inogen Inc (INGN), outlining its major shareholders and institutional holdings. It provides a breakdown of shareholder types, including investment advisors, hedge funds, and corporations, and tracks changes in institutional shareh

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 09:41
Source
TradingKey
TradingKey Direct company coverage

Inogen Inc (INGN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a brief overview of Inogen Inc's (INGN) revenue breakdown by region, indicating that 60.18% of its revenue comes from the U.S. and 39.82% from non-U.S. sources. It also lists various financial reporting periods (FY2025-FY2020) but states that relevant data f

Tone
Neutral 50/100
Event
Earnings
Published
16 Jun 2026 22:39
Source
TradingKey
TradingKey Direct company coverage

Inogen Inc (INGN) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Inogen Inc (INGN), highlighting its current market data and valuation score. The company's valuation score is 8.86, placing it 63rd in the Healthcare Equipment & Supplies industry. Key financial ratios like P/E, P/B, P/S, and P/CF are

Tone
Neutral 50/100
Event
Market update
Published
16 Jun 2026 20:10
Source
TradingKey